Federal contractors / BATTELLE MEMORIAL INSTITUTE

Federal contract award

75N93019F00131

1800013I BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2 BASE AWARD; BIOD CAN 8470038; $616,957

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIAID
NAICS541713 — Research and Development in Nanotechnology
PSCAN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Parent award / vehicle75N93018D00013
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$9.3M
Current contract value$9.3M
Potential contract value / ceiling$20.8M
Start dateJul 30, 2019
Current end dateDec 14, 2027
Potential end dateDec 14, 2027
Latest award activityMay 1, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
May 1, 2026P00011$0BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2
Dec 15, 2025P00010$2.7MBATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2
Sep 22, 2025P00009$-1.1MBATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2
Jun 18, 2024P00008$0BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2
Aug 30, 2022P00007$2.5MBATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2
May 27, 2022P00006$134.1KBATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2
Jan 26, 2022P00005$0BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2
Dec 9, 2020P00004$488.8KBATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2
Apr 16, 2020P00003$2.0MBATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2
Mar 6, 2020P00002$2.0MBATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2
Jan 9, 2020P00001$0BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2
Jul 30, 20190$617.0K1800013I BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2 BASE AWARD; BIOD CAN 8470038; $616,957

Estimated positioning window

Dec 14, 2026 – Jun 14, 2027

Recompete signal:
75/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 75/100. Available recorded signals: 70 points.

Contract end 2027-12-14 (408 days from calculation)
+25 points
13 historical awards in this buyer and category group
+15 points
12 recorded award transactions
+10 points
Latest award action: 2026-05-01
+5 points
Parent award identifier recorded
+5 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.